Korro Bio
KRRO
115 hedge funds and large institutions have $189M invested in Korro Bio in 2021 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 21 closing their positions.
76% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 21
15% more funds holding
Funds holding: 100 → 115 (+15)
0.09% less ownership
Funds ownership: 1.26% → 1.17% (-0.09%)
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
55% less call options, than puts
Call options by funds: $8.9M | Put options by funds: $19.8M
75% less capital invested
Capital invested by funds: $750M → $189M (-$561M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$72.6M |
| 2 |
Voloridge Investment Management
Jupiter,
Florida
|
+$27.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$22.8M |
| 4 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$10.3M |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$10.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$86.8M |
| 2 |
PA
Perceptive Advisors
New York
|
-$44.5M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$31.1M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$24.7M |
| 5 |
MICM
Matthews International Capital Management
San Francisco,
California
|
-$16.8M |
KRRO Hedge Fund Activity: Q1 2021 in Review
115 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q1 2021, worth a combined $189M — down 75% from $750M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new KRRO positions and 21 closed out — a net gain of 16 holders — while 31 added to existing stakes and 32 trimmed.
The largest buyer was Federated Hermes, adding an estimated $72.6M. The largest seller was RTW Investments, exiting entirely with an estimated $86.8M sold.
- 115 institutional investors held Korro Bio (KRRO) as of Q1 2021, up from 100 in Q4 2020.
- Funds reported $189M of Korro Bio stock for Q1 2021, down 75% quarter-over-quarter.
- 37 funds opened new Korro Bio positions in Q1 2021 and 21 closed out, a net change of +16 holders.
- The largest Korro Bio buyer in Q1 2021 was Federated Hermes, an estimated $72.6M added.
- The largest Korro Bio seller in Q1 2021 was RTW Investments, an estimated $86.8M sold.
Based on aggregated 13F filings for Q1 2021.